By Asian News International | Asian News International, Washington D.c. [usa]
UPDATED ON APR 18, 2019 01:59 PM IST
Adjuvant endocrine therapy (AET), such as tamoxifen, is often recommended for postmenopausal women for as long as 10 years after completion of breast cancer treatment as a means to limit the risk of cancer recurrence.
Enter your email to get our daily newsletter in your inbox
Get our daily newsletter in your inbox
Thank you for subscribing to our daily newsletter.